Precision Needle Targeting

in ultrasound-guided interventional procedures, such as regional anaesthesia and cancer biopsy

Active Needle Technology aims to enable clinicians to perform needle based procedures safely, efficiently and cost-effectively benefiting patients and healthcare providers.

Welcome to ActiveNeedle

Active Needle Technology is a pre-revenue medical device company exploiting technology developed at the University of Dundee. The company aims to commercialise its award-winning “needle actuating device” technology into a well-segmented $4+ Billion special purpose needle market, especially $1. Billion biopsy market, to enable precise needle targeting in ultrasound-guided needle interventional procedures.

Accurate needle placement via real-time visualisation and reduced tip deflection of needles is an acknowledged medical need that will increase resource-efficiency by improving the first-time success rate of needle-based procedures, minimizing procedure time and patient stress, contributing to reduced complications and re-admission rates.


  • Enhance tip visibility at even difficult angles.
  • Reduce tip deflection at deep locations.
  • Provide better penetration through tissue interfaces.
  • Reduce pain and tissue trauma.

Better Visibility and Improved Accuracy can lead to

Increased confidence of needle tip detection leading to increased uptake of ultrasound guidance.

Reduced complications and discomfort leading to better patient outcome.

Reduced re-admission rates and procedure time leading to an estimated cost savings of over $100,000/year per operation room (Marhofer, P. 2010).

ANT’s technology does not emit any ionizing radiations or any type of radiation that is linked with cancer.